机构地区:[1]Department of Pharmaceutical Chemistry and Quality Control, Faculty of Pharmacy, University of Damascus, Damascus, Syria [2]Department of Pharmaceutical Chemistry and Quality Control, Faculty of Pharmacy, University of Tartous, Tartous, Syria
出 处:《International Journal of Organic Chemistry》2021年第2期72-89,共18页有机化学国际期刊(英文)
摘 要:CDK<span style="white-space:nowrap;"><sub></span></span><sub><span style="font-family:Verdana;">2<span style="white-space:nowrap;"></sub></span></span></sub><span style="font-family:Verdana;"> is one of the most important members of Cyclin-dependent kinases. It is a critical modulator of various oncogenic signaling pathways, and its activity is vital for </span><span style="font-family:Verdana;">loss</span><span style="font-family:Verdana;"> of proliferative control during oncogenesis. This work has focused on developing a pharmacophore model for CDK<span style="white-space:nowrap;"><sub></span></span><sub><span style="font-family:Verdana;">2<span style="white-space:nowrap;"></sub></span></span></sub><span style="font-family:Verdana;"> inhibitors by using a dataset of known inhibitors as a pre-filter throughout the virtual screening and docking process. Consequently, the best pharmacophore model was made of one hydrogen bond acceptor, and two aromatic ring features with </span></span><span style="font-family:Verdana;">a </span><span style="font-family:Verdana;">high</span><span style="font-family:""><span style="font-family:Verdana;"> correlation value of 0.906. The validation findings proved out that the selected model can be used as a filter to screen new molecules like Enamine kinase hinge region directed library against CDK<span style="white-space:nowrap;"><sub></span></span><sub><span style="font-family:Verdana;">2<span style="white-space:nowrap;"></sub></span><strong></strong></span></sub><span style="font-family:Verdana;">. As a result, 69 hits were subjected to molecular docking studies. Eventually, three compounds</span></span><span style="font-family:Verdana;"> (</span><span style="font-family:""><span style="font-family:Verdana;">5909, 701 </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> 8397</span></span><span style="font-family:Verdana;">) </span><span style="font-family:""><span style="font-family:Verdana;">scored good interaction energy values and strong molecCDK<span style="white-space:nowrap;"><sub></span></span><sub><span style="font-family:Verdana;">2<span style="white-space:nowrap;"></sub></span></span></sub><span style="font-family:Verdana;"> is one of the most important members of Cyclin-dependent kinases. It is a critical modulator of various oncogenic signaling pathways, and its activity is vital for </span><span style="font-family:Verdana;">loss</span><span style="font-family:Verdana;"> of proliferative control during oncogenesis. This work has focused on developing a pharmacophore model for CDK<span style="white-space:nowrap;"><sub></span></span><sub><span style="font-family:Verdana;">2<span style="white-space:nowrap;"></sub></span></span></sub><span style="font-family:Verdana;"> inhibitors by using a dataset of known inhibitors as a pre-filter throughout the virtual screening and docking process. Consequently, the best pharmacophore model was made of one hydrogen bond acceptor, and two aromatic ring features with </span></span><span style="font-family:Verdana;">a </span><span style="font-family:Verdana;">high</span><span style="font-family:""><span style="font-family:Verdana;"> correlation value of 0.906. The validation findings proved out that the selected model can be used as a filter to screen new molecules like Enamine kinase hinge region directed library against CDK<span style="white-space:nowrap;"><sub></span></span><sub><span style="font-family:Verdana;">2<span style="white-space:nowrap;"></sub></span><strong></strong></span></sub><span style="font-family:Verdana;">. As a result, 69 hits were subjected to molecular docking studies. Eventually, three compounds</span></span><span style="font-family:Verdana;"> (</span><span style="font-family:""><span style="font-family:Verdana;">5909, 701 </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> 8397</span></span><span style="font-family:Verdana;">) </span><span style="font-family:""><span style="font-family:Verdana;">scored good interaction energy values and strong molec
关 键 词:CDK2 CANCERS Docking INHIBITORS PHARMACOPHORE Virtual Screening
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...